EU Regulators Seek Information From Drug Companies Over Patent Settlements

EU Regulators Seek Information From Drug Companies Over Patent Settlements
Bayer AG was among drug firms told by European Union antitrust officials to submit details of patent-settlement deals that may be used to delay the sale of generic versions of medicines.